Rasagiline Mesylate in Patients With Multiple System Atrophy of the Parkinsonian Subtype
- Study Title
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
- Teva Identifier
- MSA-RAS-202 | 2009-014644-11
- ClinicalTrials.gov Identifier
- NCT00977665
- Study Status
- Completed
- Trial Condition(s)
- Multiple System Atrophy
- Interventions
- Drug: rasagiline mesylate | Drug: placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 12/01/2009 - 10/01/2011
- Phase
- Phase 2
